Abivax SA Financial Overview
Abivax SA's market cap is currently €8.99B. The company's EPS TTM is €-2.1; its P/E ratio is -42.57; Abivax SA is scheduled to report earnings on December 15, 2025, and the estimated EPS forecast is €-1.30. See an overview of income statement, balance sheet, and cash flow financials.
